Literature DB >> 20590631

The contribution of reactive oxygen species and p38 mitogen-activated protein kinase to myofilament oxidation and progression of heart failure in rabbits.

P Heusch1, M Canton, S Aker, A van de Sand, I Konietzka, T Rassaf, S Menazza, O E Brodde, F Di Lisa, G Heusch, R Schulz.   

Abstract

BACKGROUND AND
PURPOSE: The formation of reactive oxygen species (ROS) is increased in heart failure (HF). However, the causal and mechanistic relationship of ROS formation with contractile dysfunction is not clear in detail. Therefore, ROS formation, myofibrillar protein oxidation and p38 MAP kinase activation were related to contractile function in failing rabbit hearts. EXPERIMENTAL APPROACH AND KEY
RESULTS: Three weeks of rapid left ventricular (LV) pacing reduced LV shortening fraction (SF, echocardiography) from 32 +/- 1% to 13 +/- 1%. ROS formation, as assessed by dihydroethidine staining, increased by 36 +/- 8% and was associated with increased tropomyosin oxidation, as reflected by dimer formation (dimer to monomer ratio increased 2.28 +/- 0.66-fold in HF vs. sham, P < 0.05). Apoptosis (TdT-mediated dUTP nick end labelling staining) increased more than 12-fold after 3 weeks of pacing when a significant increase in the phosphorylation of p38 MAP kinase and HSP27 was detected (Western blotting). Vitamins C and E abolished the increases in ROS formation and tropomyosin oxidation along with an improvement of LVSF (19 +/- 1%, P < 0.05 vs. untreated HF) and prevention of apoptosis, but without modifying p38 MAP kinase activation. Inhibition of p38 MAP kinase by SB281832 counteracted ROS formation, tropomyosin oxidation and contractile failure, without affecting apoptosis. CONCLUSIONS AND IMPLICATIONS: Thus, p38 MAP kinase activation appears to be upstream rather than downstream of ROS, which impacts on LV function through myofibrillar oxidation. p38 MAP kinase inhibition is a potential target to prevent or treat HF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590631      PMCID: PMC2938812          DOI: 10.1111/j.1476-5381.2010.00793.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  46 in total

1.  Inhibition of the Na+/H+ exchanger attenuates the deterioration of ventricular function during pacing-induced heart failure in rabbits.

Authors:  Stephanie Aker; Andrew K Snabaitis; Ina Konietzka; Anita Van De Sand; Kerstin Böngler; Metin Avkiran; Gerd Heusch; Rainer Schulz
Journal:  Cardiovasc Res       Date:  2004-08-01       Impact factor: 10.787

2.  Functional significance of myofilament protein oxidation.

Authors:  Jolanda van der Velden
Journal:  Eur Heart J       Date:  2006-01-24       Impact factor: 29.983

3.  Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization.

Authors:  Marcella Canton; Andreas Skyschally; Roberta Menabò; Kerstin Boengler; Petra Gres; Rainer Schulz; Michael Haude; Raimund Erbel; Fabio Di Lisa; Gerd Heusch
Journal:  Eur Heart J       Date:  2006-01-24       Impact factor: 29.983

4.  p38 mitogen activated protein kinase mediates both death signaling and functional depression in the heart.

Authors:  Meijing Wang; Ben M Tsai; Mark W Turrentine; Yousuf Mahomed; John W Brown; Daniel R Meldrum
Journal:  Ann Thorac Surg       Date:  2005-12       Impact factor: 4.330

Review 5.  Reactive oxygen species in cardiac signalling: from mitochondria to plasma membrane ion channels.

Authors:  Livia C Hool
Journal:  Clin Exp Pharmacol Physiol       Date:  2006 Jan-Feb       Impact factor: 2.557

6.  Antioxidants attenuate myocyte apoptosis and improve cardiac function in CHF: association with changes in MAPK pathways.

Authors:  Fuzhong Qin; Junya Shite; Chang-seng Liang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-04-24       Impact factor: 4.733

7.  p38-MAPK induced dephosphorylation of alpha-tropomyosin is associated with depression of myocardial sarcomeric tension and ATPase activity.

Authors:  Susan Vahebi; Asuka Ota; Manxiang Li; Chad M Warren; Pieter P de Tombe; Yibin Wang; R John Solaro
Journal:  Circ Res       Date:  2007-01-18       Impact factor: 17.367

Review 8.  Potential of p38-MAPK inhibitors in the treatment of ischaemic heart disease.

Authors:  James E Clark; Negin Sarafraz; Michael S Marber
Journal:  Pharmacol Ther       Date:  2007-07-24       Impact factor: 12.310

9.  G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.

Authors:  Philip W Raake; Leif E Vinge; Erhe Gao; Matthieu Boucher; Giuseppe Rengo; Xiongwen Chen; Brent R DeGeorge; Scot Matkovich; Steven R Houser; Patrick Most; Andrea D Eckhart; Gerald W Dorn; Walter J Koch
Journal:  Circ Res       Date:  2008-07-17       Impact factor: 17.367

10.  Inhibition of Na+/H+-exchanger with sabiporide attenuates the downregulation and uncoupling of the myocardial beta-adrenoceptor system in failing rabbit hearts.

Authors:  Kirsten Leineweber; Stephanie Aker; Anja Beilfuss; Heike Rekasi; Ina Konietzka; Claus Martin; Gerd Heusch; Rainer Schulz
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

View more
  27 in total

1.  Myocardial infarction in mice alters sarcomeric function via post-translational protein modification.

Authors:  Benjamin S Avner; Krystyna M Shioura; Sarah B Scruggs; Milana Grachoff; David L Geenen; Donald L Helseth; Mariam Farjah; Paul H Goldspink; R John Solaro
Journal:  Mol Cell Biochem       Date:  2011-12-08       Impact factor: 3.396

2.  β₂-Adrenoceptors, NADPH oxidase, ROS and p38 MAPK: another 'radical' road to heart failure?

Authors:  Fabio Di Lisa; Nina Kaludercic; Nazareno Paolocci
Journal:  Br J Pharmacol       Date:  2011-03       Impact factor: 8.739

Review 3.  Role of heart rate as a marker and mediator of poor outcome for patients with heart failure.

Authors:  John R Kapoor; Paul A Heidenreich
Journal:  Curr Heart Fail Rep       Date:  2012-06

4.  A change of heart: oxidative stress in governing muscle function?

Authors:  Martin Breitkreuz; Nazha Hamdani
Journal:  Biophys Rev       Date:  2015-06-27

5.  Sphingomyelinase depresses force and calcium sensitivity of the contractile apparatus in mouse diaphragm muscle fibers.

Authors:  Leonardo F Ferreira; Jennifer S Moylan; Shawn Stasko; Jeffrey D Smith; Kenneth S Campbell; Michael B Reid
Journal:  J Appl Physiol (1985)       Date:  2012-02-23

Review 6.  Fetal stress and programming of hypoxic/ischemic-sensitive phenotype in the neonatal brain: mechanisms and possible interventions.

Authors:  Yong Li; Pablo Gonzalez; Lubo Zhang
Journal:  Prog Neurobiol       Date:  2012-05-22       Impact factor: 11.685

7.  Metabolomic analysis of serum and myocardium in compensated heart failure after myocardial infarction.

Authors:  M Dan McKirnan; Yasuhiro Ichikawa; Zheng Zhang; Alice E Zemljic-Harpf; Sili Fan; Dinesh Kumar Barupal; Hemal H Patel; H Kirk Hammond; David M Roth
Journal:  Life Sci       Date:  2019-02-05       Impact factor: 5.037

8.  The role of Nrf2 in skeletal muscle contractile and mitochondrial function.

Authors:  Matthew J Crilly; Liam D Tryon; Avigail T Erlich; David A Hood
Journal:  J Appl Physiol (1985)       Date:  2016-07-28

9.  Activation of p38 MAP kinase and JNK pathways by UVA irradiation.

Authors:  Jack Zhang; G Tim Bowden
Journal:  Photochem Photobiol Sci       Date:  2011-08-22       Impact factor: 3.982

Review 10.  The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox.

Authors:  Demetrios Moris; Michael Spartalis; Eleftherios Spartalis; Georgia-Sofia Karachaliou; Georgios I Karaolanis; Gerasimos Tsourouflis; Diamantis I Tsilimigras; Eleni Tzatzaki; Stamatios Theocharis
Journal:  Ann Transl Med       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.